Department of Pediatric Nephrology, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan; Kidney Disease Research Institute, Tokiwa Foundation, Jyoban Hospital, Iwaki, Fukushima, Japan.
Kidney Int. 2024 Oct;106(4):570-572. doi: 10.1016/j.kint.2024.08.004.
Post-transplant recurrence of focal segmental glomerular sclerosis (FSGS) is a major challenge in the field of kidney transplantation. Currently, the most reliable predictor of FSGS recurrence is disease recurrence in a previous allograft. Recent studies suggest a possible causal role of anti-nephrin autoantibodies in the primary disease (primary FSGS and minimal change disease), as well as post-transplant recurrence of FSGS. In this issue of Kidney International, Batal et al. evaluate pretransplant anti-nephrin autoantibodies as a specific predictor of FSGS recurrence and demonstrate colocalization of nephrin and punctate IgG in anti-nephrin-positive patients with disease recurrence.
移植后局灶节段性肾小球硬化症 (FSGS) 的复发是肾移植领域的一个主要挑战。目前,FSGS 复发最可靠的预测因子是既往同种异体移植物中的疾病复发。最近的研究表明,抗肾络蛋白自身抗体在原发性疾病(原发性 FSGS 和微小病变性肾病)以及 FSGS 的移植后复发中可能具有因果作用。在本期《国际肾脏》杂志中,Batal 等人评估了移植前抗肾络蛋白自身抗体作为 FSGS 复发的特异性预测因子,并证明在疾病复发的抗肾络蛋白阳性患者中,肾络蛋白和点状 IgG 共定位。